Generali SpA

    premises & global services
                             

    Financial calendar

    Financial calendar

    March

    • 14 Mar 2018

      Financial events

      Board of Directors - Approval of consolidated financial statements and draft separate financial statements for the year to 31 December 2017

    • 15 Mar 2018

      Financial events

      Results release

    April

    • 19 Apr 2018

      Financial events

      Annual General Meeting - Approval of the 2017 separate financial statements

    May

    • 03 May 2018

      Financial events

      Board of Directors - Approval of the quarterly report at 31 March 2018

    • 04 May 2018

      Financial events

      Results release

    • 21 May 2018

      Financial events

      Ex Dividend date - Generali share ex-dividend date

    • 23 May 2018

      Financial events

      Dividend payment - Generali share dividend payment date

      Add to calendar

    July

    • 31 Jul 2018

      Financial events

      Board of Directors - Approval of the half-year report at 30 June 2018

      Add to calendar

    August

    • 01 Aug 2018

      Financial events

      Results release

      Add to calendar

    November

    • 07 Nov 2018

      Financial events

      Board of Directors - Approval of the report to the 9 months at 30 September 2018

      Add to calendar

    • 08 Nov 2018

      Financial events

      Results release

      Add to calendar

    The dates given above are provided purely as general indications: any changes will be promptly announced to the market, using the channels used to distribute this statement.

    The dates of the meetings with the investors will be communicated once set.


    Please note that the above dates are purely for information purposes. Any change will be promptly disclosed to the market and published on the website.  
    The group will normally apply a closed period of four weeks before the publication of results, and before major events like Investor Days or Annual General Meetings. During this time, we will not arrange investor or analyst meetings or attend conferences. Investor & Rating Agency Relations team will remain available to respond to fact based information requests during this period.